Tricuspid Valve Repair System
Tricuspid Regurgitation
Key Facts
Indication
Tricuspid Regurgitation
Phase
Clinical Investigation
Status
Active (TRILUMINATE Pivotal)
Company
About Abbott
Abbott Laboratories is a diversified healthcare giant with a mission to advance human health through accessible, innovative solutions across the care continuum. Its strategic achievements are anchored in market-leading franchises like the FreeStyle Libre continuous glucose monitoring system and the Alinity diagnostic platform, driving consistent growth. The company's strategy balances deep R&D investment in high-growth areas like diabetes and cardiovascular care with a disciplined focus on operational efficiency and geographic expansion, particularly in emerging markets. This approach has solidified its position as a mature, financially robust enterprise with a $179.44B market capitalization.
View full company profileTherapeutic Areas
Other Tricuspid Regurgitation Drugs
| Drug | Company | Phase |
|---|---|---|
| MIA-T Percutaneous Tricuspid Annuloplasty System | Micro Interventional Devices | Clinical Trial |